Published in Pediatr Res on January 01, 2003
Epigenetic silencing of nucleolar rRNA genes in Alzheimer's disease. PLoS One (2011) 1.07
Neurotoxic mechanisms of DNA damage: focus on transcriptional inhibition. J Neurochem (2010) 0.88
Autocrine PDGFR signaling promotes mammary cancer metastasis. J Clin Invest (2006) 2.68
Expression profiling of epithelial plasticity in tumor progression. Oncogene (2003) 2.67
The sedoheptulose kinase CARKL directs macrophage polarization through control of glucose metabolism. Cell Metab (2012) 2.36
Aberrant expression of peroxiredoxin subtypes in neurodegenerative disorders. Brain Res (2003) 1.77
The proteomic analysis of primary cortical astrocyte cell culture after morphine administration. J Proteome Res (2009) 1.55
Characterization of Toll-like receptors in primary lung epithelial cells: strong impact of the TLR3 ligand poly(I:C) on the regulation of Toll-like receptors, adaptor proteins and inflammatory response. J Inflamm (Lond) (2005) 1.50
Myelin-mediated inhibition of oligodendrocyte precursor differentiation can be overcome by pharmacological modulation of Fyn-RhoA and protein kinase C signalling. Brain (2009) 1.49
Skeletal, cardiac and tongue muscle pathology, defective retinal transmission, and neuronal migration defects in the Large(myd) mouse defines a natural model for glycosylation-deficient muscle - eye - brain disorders. Hum Mol Genet (2002) 1.36
Drebrin, a dendritic spine protein, is manifold decreased in brains of patients with Alzheimer's disease and Down syndrome. Neurosci Lett (2002) 1.33
Limitations of current proteomics technologies. J Chromatogr A (2005) 1.28
Overexpressed protein disulfide isomerase in brains of patients with sporadic Creutzfeldt-Jakob disease. Neurosci Lett (2002) 1.27
Rescue of impaired fear extinction and normalization of cortico-amygdala circuit dysfunction in a genetic mouse model by dietary zinc restriction. J Neurosci (2010) 1.25
Coronary no-reflow is caused by shedding of active tissue factor from dissected atherosclerotic plaque. Blood (2002) 1.21
Vasoactive intestinal peptide as a new drug for treatment of primary pulmonary hypertension. J Clin Invest (2003) 1.21
Evaluation of spatial memory of C57BL/6J and CD1 mice in the Barnes maze, the Multiple T-maze and in the Morris water maze. Behav Brain Res (2008) 1.15
Ca(2+)/calmodulin-dependent protein kinase IIα (αCaMKII) controls the activity of the dopamine transporter: implications for Angelman syndrome. J Biol Chem (2012) 1.14
Contribution of human amniotic fluid stem cells to renal tissue formation depends on mTOR. Hum Mol Genet (2010) 1.11
Neuronal nitric oxide synthase knock-out mice show impaired cognitive performance. Nitric Oxide (2004) 1.09
Stomatin is a major lipid-raft component of platelet alpha granules. Blood (2002) 1.06
Expressional patterns of chaperones in ten human tumor cell lines. Proteome Sci (2004) 1.05
Aberrant expression of signaling-related proteins 14-3-3 gamma and RACK1 in fetal Down syndrome brain (trisomy 21). Electrophoresis (2002) 1.04
p27Kip1 localization depends on the tumor suppressor protein tuberin. Hum Mol Genet (2007) 1.02
HUPO Brain Proteome Project: summary of the pilot phase and introduction of a comprehensive data reprocessing strategy. Proteomics (2006) 1.02
Protein profile of the HeLa cell line. J Chromatogr A (2004) 1.02
A rat brain protein expression map including cytosolic and enriched mitochondrial and microsomal fractions. Electrophoresis (2003) 1.01
Activation of ectopic Oct-4 and Rex-1 promoters in human amniotic fluid cells. Int J Mol Med (2005) 1.01
Proteomic analysis of the fetal brain. Proteomics (2002) 1.00
Elevated expression of TARC (CCL17) and MDC (CCL22) in models of cigarette smoke-induced pulmonary inflammation. Biochem Biophys Res Commun (2005) 0.99
Comparison of fluorescent labels for oligosaccharides and introduction of a new postlabeling purification method. Anal Biochem (2008) 0.96
The amniotic fluid cell proteome. Electrophoresis (2005) 0.94
Adaptation of the "in-gel release method" to N-glycome analysis of low-milligram amounts of material. Electrophoresis (2007) 0.93
Gel-based mass spectrometric analysis of recombinant GABA(A) receptor subunits representing strongly hydrophobic transmembrane proteins. J Proteome Res (2008) 0.92
Increased protein synthesis by cells exposed to a 1,800-MHz radio-frequency mobile phone electromagnetic field, detected by proteome profiling. Int Arch Occup Environ Health (2010) 0.91
Impaired cognitive performance in neuronal nitric oxide synthase knockout mice is associated with hippocampal protein derangements. Nitric Oxide (2004) 0.91
Expression of cystathionine beta-synthase, pyridoxal kinase, and ES1 protein homolog (mitochondrial precursor) in fetal Down syndrome brain. Neurochem Int (2004) 0.90
Decreased social interaction in aged rats may not reflect changes in anxiety-related behaviour. Behav Brain Res (2004) 0.89
The rat brain hippocampus proteome. J Chromatogr B Analyt Technol Biomed Life Sci (2005) 0.89
Crystal and solution structure, stability and post-translational modifications of collapsin response mediator protein 2. FEBS J (2008) 0.89
Human brain nucleoside diphosphate kinase activity is decreased in Alzheimer's disease and Down syndrome. Biochem Biophys Res Commun (2002) 0.89
Structural analysis of the complex between calmodulin and full-length myelin basic protein, an intrinsically disordered molecule. Amino Acids (2009) 0.88
Protein L-isoaspartyl methyltransferase regulates p53 activity. Nat Commun (2012) 0.88
Human brain nascent polypeptide-associated complex alpha subunit is decreased in patients with Alzheimer' s disease and Down syndrome. J Investig Med (2002) 0.88
Reduction of actin-related protein complex 2/3 in fetal Down syndrome brain. Biochem Biophys Res Commun (2002) 0.88
Gel-based mass spectrometric analysis of a strongly hydrophobic GABAA-receptor subunit containing four transmembrane domains. Nat Protoc (2009) 0.88
Lyophilization is suitable for storage and shipment of fresh tissue samples without altering RNA and protein levels stored at room temperature. Amino Acids (2012) 0.87
Reduction of hippocampal collapsin response mediated protein-2 in patients with mesial temporal lobe epilepsy. Neurochem Res (2004) 0.87
Expression patterns of antioxidant proteins in brains of patients with sporadic Creutzfeldt-Jacob disease. Electrophoresis (2002) 0.87
Manufacturing of peptides exhibiting biological activity. Amino Acids (2012) 0.87
Inhibition of oligodendrocyte precursor cell differentiation by myelin-associated proteins. Neurosurg Focus (2008) 0.87
Changes in brain protein expression are linked to magnesium restriction-induced depression-like behavior. Amino Acids (2011) 0.87
Fetal Down syndrome brains exhibit aberrant levels of neurotransmitters critical for normal brain development. Pediatrics (2007) 0.87
Scopolamine administration modulates muscarinic, nicotinic and NMDA receptor systems. PLoS One (2012) 0.86
Manifold decreased protein levels of matrin 3, reduced motor protein HMP and hlark in fetal Down's syndrome brain. Proteomics (2002) 0.86
Aberrant neuronal and mitochondrial proteins in hippocampus of transgenic mice overexpressing human Cu/Zn superoxide dismutase 1. Free Radic Biol Med (2004) 0.86
Strain-dependent regulation of plasticity-related proteins in the mouse hippocampus. Behav Brain Res (2005) 0.86
Proteomic analysis of striatal neuronal cell cultures after morphine administration. J Sep Sci (2009) 0.85
Tuberin--a new molecular target in Alzheimer's disease? Neurochem Res (2005) 0.85
Silk cocoon of Bombyx mori: proteins and posttranslational modifications--heavy phosphorylation and evidence for lysine-mediated cross links. Proteomics (2010) 0.85
Protein profiles of medulloblastoma cell lines DAOY and D283: identification of tumor-related proteins and principles. Proteomics (2003) 0.85
Hippocampal protein levels related to spatial memory are different in the Barnes maze and in the multiple T-maze. J Proteome Res (2009) 0.85
Immunological and ultrastructural characterization of endothelial cell cultures differentiated from human cord blood derived endothelial progenitor cells. Histochem Cell Biol (2006) 0.85
Metalloproteinase ADAMTS-1 but not ADAMTS-5 is manifold overexpressed in neurodegenerative disorders as Down syndrome, Alzheimer's and Pick's disease. Brain Res Mol Brain Res (2005) 0.84
Proteomic analysis of rat cerebral cortex, hippocampus and striatum after exposure to morphine. Int J Mol Med (2006) 0.84
Proteomic profiling of human hippocampus. Electrophoresis (2004) 0.84
Strain-dependent effects of SGS742 in the mouse. Behav Brain Res (2007) 0.84
Congenital lack of nNOS impairs long-term social recognition memory and alters the olfactory bulb proteome. Neurobiol Learn Mem (2009) 0.84
Proteome analysis of primary neurons and astrocytes from rat cerebellum. J Proteome Res (2005) 0.84
Inhibition of phosphodiesterase-4 promotes oligodendrocyte precursor cell differentiation and enhances CNS remyelination. EMBO Mol Med (2013) 0.84
Association of vasoactive intestinal peptide with polymer-grafted liposomes: structural aspects for pulmonary delivery. Biochim Biophys Acta (2006) 0.84
Possible dysregulation of chaperon and metabolic proteins in cystic fibrosis bronchial tissue. Proteomics (2006) 0.84
Perinatal asphyxia in the rat has lifelong effects on morphology, cognitive functions, and behavior. Semin Perinatol (2004) 0.83
Dysregulation of growth factor receptor-bound protein 2 and fascin in hippocampus of mice polytransgenic for chromosome 21 structures. Hippocampus (2007) 0.83
In vitro anti-cancer activity of two ethno-pharmacological healing plants from Guatemala Pluchea odorata and Phlebodium decumanum. Int J Oncol (2009) 0.83
Differentiation of neuroblastoma cell line N1E-115 involves several signaling cascades. Neurochem Res (2005) 0.83
Mass spectrometrical analysis of cuticular proteins from the wing of Hebemoia glaucippe (Linnaeus, 1758) (Lepidoptera: Pieridae). J Proteomics (2011) 0.83
Hippocampal signaling cascades are modulated in voluntary and treadmill exercise rats. Electrophoresis (2007) 0.83
Focal adhesion kinase regulates neuronal growth, synaptic plasticity and hippocampus-dependent spatial learning and memory. Neurosignals (2011) 0.83
Molecular changes in fetal Down syndrome brain. J Neurochem (2003) 0.83
Identification of enzymes and activity from two-dimensional gel electrophoresis. Nat Protoc (2007) 0.82
Use of solution-IEF-fractionation leads to separation of 2673 mouse brain proteins including 255 hydrophobic structures. J Proteome Res (2006) 0.82
Vasoactive intestinal peptide gene alterations in patients with idiopathic pulmonary arterial hypertension. Eur J Hum Genet (2006) 0.82
Protein profiling by the combination of two independent mass spectrometry techniques. Nat Protoc (2006) 0.82
Depot formulation of vasoactive intestinal peptide by protamine-based biodegradable nanoparticles. J Control Release (2008) 0.82
Variations of protein levels in human amniotic fluid stem cells CD117/2 over passages 5-25. J Proteome Res (2009) 0.82
The N-terminal domain of the myelin enzyme 2',3'-cyclic nucleotide 3'-phosphodiesterase: direct molecular interaction with the calcium sensor calmodulin. J Neurochem (2012) 0.82
A gel-based proteomic method reveals several protein pathway abnormalities in fetal Down syndrome brain. J Proteomics (2011) 0.82
Proteomic evaluation of intermediary metabolism enzyme proteins in fetal Down's syndrome cerebral cortex. Proteomics (2002) 0.82
Proteomic differences between tellurite-sensitive and tellurite-resistant E.coli. PLoS One (2013) 0.82
Multifunctional peptides derived from an egg yolk protein hydrolysate: isolation and characterization. Amino Acids (2014) 0.82
Inhalable liposomal formulation for vasoactive intestinal peptide. Int J Pharm (2008) 0.82
VPAC receptor mediated tumor cell targeting by protamine based nanoparticles. J Drug Target (2010) 0.81
Mass spectrometric analysis of GABAA receptor subtypes and phosphorylations from mouse hippocampus. Proteomics (2011) 0.81
Proteomic determination of metabolic enzymes of the amnion cell: basis for a possible diagnostic tool? Proteomics (2004) 0.81